Impact of androgen deprivation therapy on sexual function: a response
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
Dear Editors,
We appreciate the growing interest in sexual health for cancer patients and survivors.Mazzola and Mulhall’s recent paper,1 however,creates the impression that rewarding sex is not possible for prostate cancer patients on androgen deprivation therapy (ADT).This impression,we believe,is not scientifically justified,and may be a disservice to prostate cancer patients and their partners in that it could act as a negative placebo,i.e,,the opposite of an aphrodisiac.It was unfortunate that the authors did not use their paper to explore positive pathways for sexual interaction and arousal among ADT patients.Instead,readers may be left with a rather discouraging outlook on the prospect of sexual intimacy and pleasure for androgen deprived cancer patients.